Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
INMD Stock Forecast 2026-2027
$15.60
Current Price
$896.41M
Market Cap
Buy 0
Hold 5
Sell 0
Wall St Analyst Ratings
Distance to INMD Price Targets
+9.0%
To High Target of $17.00
-3.8%
To Median Target of $15.00
-10.2%
To Low Target of $14.00
INMD Price Momentum
+2.1%
1 Week Change
+16.8%
1 Month Change
+10.6%
1 Year Change
+6.2%
Year-to-Date Change
-6.8%
From 52W High of $16.74
+22.6%
From 52W Low of $12.72
📊 TOP ANALYST CALLS
Did INMD Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Inmode is one of their latest high-conviction picks.
Latest INMD Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, INMD has a neutral consensus with a median price target of $15.00 (ranging from $14.00 to $17.00). The overall analyst rating is Buy (6.0/10). Currently trading at $15.60, the median forecast implies a -3.8% downside. This outlook is supported by 0 Buy, 5 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Jeff Johnson at Baird, suggesting a 10.2% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
INMD Analyst Ratings
0
Buy
5
Hold
0
Sell
INMD Price Target Range
Low
$14.00
Average
$15.00
High
$17.00
Current: $15.60
Latest INMD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for INMD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 7, 2026 | Barclays | Matt Miksic | Overweight | Maintains | $19.00 |
| May 7, 2026 | Baird | Jeff Johnson | Neutral | Maintains | $14.00 |
| Dec 17, 2025 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Nov 6, 2025 | UBS | Neutral | Maintains | $N/A | |
| Oct 10, 2025 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Oct 10, 2025 | Needham | Hold | Reiterates | $N/A | |
| Jul 30, 2025 | Needham | Hold | Reiterates | $N/A | |
| Jul 30, 2025 | Barclays | Overweight | Maintains | $N/A | |
| Jul 11, 2025 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Apr 30, 2025 | Barclays | Overweight | Maintains | $N/A | |
| Apr 29, 2025 | UBS | Neutral | Maintains | $N/A | |
| Apr 29, 2025 | BTIG | Neutral | Downgrade | $N/A | |
| Apr 29, 2025 | Canaccord Genuity | Hold | Maintains | $N/A | |
| Apr 28, 2025 | Needham | Hold | Reiterates | $N/A | |
| Apr 14, 2025 | Jefferies | Hold | Maintains | $N/A | |
| Apr 14, 2025 | Needham | Hold | Reiterates | $N/A | |
| Apr 9, 2025 | Needham | Hold | Reiterates | $N/A | |
| Feb 5, 2025 | Barclays | Overweight | Maintains | $N/A | |
| Feb 4, 2025 | Needham | Hold | Maintains | $N/A | |
| Jan 9, 2025 | Barclays | Overweight | Maintains | $N/A |
InMode Ltd. (INMD) Competitors
The following stocks are similar to Inmode based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
InMode Ltd. (INMD) Financial Data
InMode Ltd. has a market capitalization of $896.41M with a P/E ratio of 11.6x. The company generates $374.64M in trailing twelve-month revenue with a 23.3% profit margin.
Revenue growth is +5.3% quarter-over-quarter, while maintaining an operating margin of +12.3% and return on equity of +13.6%.
Valuation Metrics
Market Cap
$896.41M
Enterprise Value
$436.44M
P/E Ratio
11.6x
PEG Ratio
-0.4x
Price/Sales
2.4x
Growth & Margins
Revenue Growth (YoY)
+5.3%
Gross Margin
+75.0%
Operating Margin
+12.3%
Net Margin
+23.3%
EPS Growth
-36.5%
Financial Health
Cash/Price Ratio
+54.3%
Current Ratio
8.8x
Debt/Equity
0.7x
ROE
+13.6%
ROA
+6.9%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
InMode Ltd. (INMD) Business Model
About InMode Ltd.
What They Do
Develops innovative medical aesthetic devices.
Business Model
The company designs, manufactures, and markets medical aesthetic devices using proprietary radiofrequency technology. It generates revenue by selling these devices to healthcare professionals in various specialties, including plastic surgery and dermatology, through a global network of distributors.
Additional Information
Founded in 2008 and headquartered in Yokneam, Israel, InMode Ltd. focuses on minimally invasive and non-invasive procedures, addressing a wide range of aesthetic and wellness needs. The company serves an international market, including the US, Canada, Europe, and Asia.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
660
CEO
Mr. Moshe Mizrahy
Country
Israel
IPO Year
2019
Website
www.inmodemd.comInMode Ltd. (INMD) Latest News & Analysis
Latest News
Quick Summary
InMode Ltd. (NASDAQ: INMD) will release its Q2 2026 financial results on August 5, 2026, prior to the Nasdaq market opening.
Why It Matters
InMode Ltd.'s upcoming Q2 2026 financial results could impact stock performance, reflecting company growth or challenges and influencing investor sentiment and market positioning.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Steel Partners Holdings has proposed to acquire InMode Ltd. for $16.75 per share in cash, addressing the company's Board of Directors in a formal letter.
Why It Matters
Steel Partners' acquisition offer at $16.75 per share for InMode could signal potential value realization for investors, impacting stock price and market sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
InMode Ltd. (NASDAQ: INMD) announced that its Board received an unsolicited acquisition proposal from Steel Partners Holdings L.P. on July 10, 2026.
Why It Matters
The unsolicited acquisition proposal from Steel Partners may indicate potential value changes for InMode Ltd., affecting stock price and investor sentiment.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
The Law Offices of Howard G. Smith are investigating InMode Ltd. (NASDAQ: INMD) for potential federal securities law violations, encouraging affected investors to pursue claims.
Why It Matters
An investigation into InMode Ltd. for potential securities law violations may signal financial instability or legal troubles, impacting investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Glancy Prongay Wolke & Rotter LLP is investigating InMode Ltd. (NASDAQ: INMD) for potential federal securities law violations, affecting investors who may have lost money.
Why It Matters
The investigation into InMode Ltd. signals potential legal issues, which may lead to financial losses for shareholders and affect stock performance and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
The Law Offices of Frank R. Cruz are investigating InMode Ltd. (NASDAQ: INMD) for potential federal securities law violations, affecting investors who may have lost money.
Why It Matters
The investigation into InMode Ltd. for potential federal securities law violations raises concerns about legal risks and financial losses, impacting investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About INMD Stock
What is InMode Ltd.'s (INMD) stock forecast for 2027?
Based on our analysis of 3 Wall Street analysts, InMode Ltd. (INMD) has a median price target of $15.00. The highest price target is $17.00 and the lowest is $14.00.
Is INMD stock a good investment in 2027?
According to current analyst ratings, INMD has 0 Buy ratings, 5 Hold ratings, and 0 Sell ratings. The stock is currently trading at $15.60. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for INMD stock?
Wall Street analysts predict INMD stock could reach $15.00 in the next 12 months. This represents a -3.8% decrease from the current price of $15.60. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is InMode Ltd.'s business model?
The company designs, manufactures, and markets medical aesthetic devices using proprietary radiofrequency technology. It generates revenue by selling these devices to healthcare professionals in various specialties, including plastic surgery and dermatology, through a global network of distributors.
What is the highest forecasted price for INMD InMode Ltd.?
The highest price target for INMD is $17.00 from at , which represents a 9.0% increase from the current price of $15.60.
What is the lowest forecasted price for INMD InMode Ltd.?
The lowest price target for INMD is $14.00 from Jeff Johnson at Baird, which represents a -10.2% decrease from the current price of $15.60.
What is the overall INMD consensus from analysts for InMode Ltd.?
The overall analyst consensus for INMD is neutral. Out of 3 Wall Street analysts, 0 rate it as Buy, 5 as Hold, and 0 as Sell, with a median price target of $15.00.
How accurate are INMD stock price projections?
Stock price projections, including those for InMode Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 17, 2026 2:43 AM UTC